336 related articles for article (PubMed ID: 6376858)
21. [Pharmacokinetic, bacteriological and clinical studies on cefozopran in the pediatric field].
Motohiro T; Handa S; Yamada S; Sasaki H; Oki S; Yoshinaga Y; Oda K; Aramaki M; Sakata Y; Yamashita F
Jpn J Antibiot; 1994 Nov; 47(11):1589-611. PubMed ID: 7853690
[TBL] [Abstract][Full Text] [Related]
22. [Pharmacokinetic and clinical studies on cefozopran in the field of pediatrics].
Kaino Y; Kida K; Matsuda H
Jpn J Antibiot; 1994 Nov; 47(11):1565-75. PubMed ID: 7853687
[TBL] [Abstract][Full Text] [Related]
23. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H
Jpn J Antibiot; 1995 Nov; 48(11):1757-87. PubMed ID: 8558757
[TBL] [Abstract][Full Text] [Related]
24. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
[TBL] [Abstract][Full Text] [Related]
25. [Experimental and clinical evaluation of cefpiramide in pediatrics].
Iwai N; Mizoguchi F; Sasaki A; Taneda Y; Nakamura H
Jpn J Antibiot; 1983 Aug; 36(8):2242-60. PubMed ID: 6655844
[TBL] [Abstract][Full Text] [Related]
26. [Fundamental and clinical studies on cefminox in the field of pediatrics].
Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
Jpn J Antibiot; 1985 Mar; 38(3):705-19. PubMed ID: 3897604
[TBL] [Abstract][Full Text] [Related]
27. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Fujime M; Fujita K; Shigeta S; Watanabe J; Igari J; Ogiwara M; Ishibashi K; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Matsumoto T; Kashitani F; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Mochida C
Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177
[TBL] [Abstract][Full Text] [Related]
28. [Basic and clinical studies on T-1982 (cefbuperazone) in the field of pediatrics].
Iwai N; Taneda Y; Sasaki A; Mizoguchi F; Nakamura H
Jpn J Antibiot; 1983 Apr; 36(4):803-25. PubMed ID: 6348336
[TBL] [Abstract][Full Text] [Related]
29. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754
[TBL] [Abstract][Full Text] [Related]
30. [Laboratory and clinical studies on 6059-S in children (author's transl)].
Iwai N; Sasaki A; Taneda Y; Osuga T; Inokuma K
Jpn J Antibiot; 1981 May; 34(5):782-99. PubMed ID: 6457176
[TBL] [Abstract][Full Text] [Related]
31. [Clinical evaluation of ceftazidime in paediatrics].
Haruta T; Ohkura K; Kuroki S; Kobayashi Y
Jpn J Antibiot; 1984 Mar; 37(3):524-36. PubMed ID: 6376860
[TBL] [Abstract][Full Text] [Related]
32. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Takanashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Kosakai N; Yamaguchi K; Matsumoto T; Kashitani F; Tanaka M
Jpn J Antibiot; 1997 Mar; 50(3):219-50. PubMed ID: 9575353
[TBL] [Abstract][Full Text] [Related]
33. [Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
Iwata S; Sato Y; Iwasaki Y; Hayano S; Wakabayashi R; Kojima Y; Akita H; Sunakawa K; Oikawa T; Osano M
Jpn J Antibiot; 1984 Oct; 37(10):1831-45. PubMed ID: 6094863
[TBL] [Abstract][Full Text] [Related]
34. [Bacteriological, pharmacokinetic and clinical studies on cefpodoxime proxetil in the pediatric field].
Toyonaga Y; Koizumi M; Imai H; Sugita M; Takahashi T; Fukushima Y; Yamasaki M; Hori M
Jpn J Antibiot; 1989 Jul; 42(7):1519-46. PubMed ID: 2810728
[TBL] [Abstract][Full Text] [Related]
35. [Laboratory and clinical studies of cefoperazone in children (author's transl)].
Iwai N; Sasaki A; Miyazu M; Osuga T; Inokuma K
Jpn J Antibiot; 1980 Sep; 33(9):871-90. PubMed ID: 6452536
[TBL] [Abstract][Full Text] [Related]
36. [Laboratory and clinical studies on T-1982 (cefbuperazone) in the field of pediatrics].
Toyonaga Y; Kurosu Y; Koda N; Ida H; Mochizuki H; Kumagai K; Akatsuka J; Sugita M; Kawamura G; Okabe T; Hori M; Takahashi T
Jpn J Antibiot; 1983 Apr; 36(4):739-70. PubMed ID: 6410101
[TBL] [Abstract][Full Text] [Related]
37. [Fundamental and clinical studies of ceftazidime in the pediatric field].
Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K
Jpn J Antibiot; 1984 Mar; 37(3):537-53. PubMed ID: 6376861
[TBL] [Abstract][Full Text] [Related]
38. [Fundamental and clinical studies of ceftazidime in the field of pediatrics].
Terashima I; Nakamura A; Okimoto Y; Sugaya N; Kurosaki T; Himi K; Yamazaki T; Uehara S
Jpn J Antibiot; 1984 Mar; 37(3):355-62. PubMed ID: 6376849
[TBL] [Abstract][Full Text] [Related]
39. [Laboratory and clinical studies of cefuzonam in pediatric field].
Nishimura T; Tabuki K; Takashima T; Takagi M
Jpn J Antibiot; 1987 Feb; 40(2):427-38. PubMed ID: 3599391
[TBL] [Abstract][Full Text] [Related]
40. [Studies on sulbactam/cefoperazone in the field of pediatrics].
Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
Jpn J Antibiot; 1984 Oct; 37(10):1859-79. PubMed ID: 6094865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
